Clinical trials sponsored by University of Cape Town

Phase breakdown

Conditions studied

Recruiting trials led by University of Cape Town

• Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
  NCT04147286 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV
  NCT05923333 · Phase: Not applicable (e.g. observational or device study) · Ages: 0 Days to 50 Years · Sex: All (male and female) · 1 location
• B.R.A.I.N in People Living With HIV Study
  NCT06466642 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 50 Years · Sex: All (male and female) · 3 locations
• High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
  NCT04521803 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Remote Ischaemic Conditioning in STEMI Patients in AFRICA
  NCT04813159 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 20 locations

Common questions

How many trials is University of Cape Town recruiting for?

University of Cape Town is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.